BridgeMD
New treatment option for Neglect, Hemispatial
Official title Implementation of IVS3 for Upper Limb Motor Recovery
ClinicalTrials.gov ID: NCT06483230
What this study is testing
- What it's testing
- This study measures participant satisfaction and upper extremity function in outpatients with chronic stroke when exposed to the IVS3 device. Investigators hypothesize that treatment with the IVS3 device will be feasible and tolerable for use in the outpatient setting.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years old
- English speaking
- History of ischemic or hemorrhagic stroke ≥ 6 months prior to study enrolment
- FMA-UE: 20 \< x \< 50 (moderate impairments)
- With or without hemi spatial neglect
You likely can't join if
- Spasticity or increased tone with MAS ≥3 in the upper extremity
- Unable to communicate effectively or provide informed consent
- Significant visual impairments
- Concurrent occupational therapy being received outside of the study
- Pregnant or incarcerated individuals
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.